| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Endotoxemia | 13 | 2021 | 143 | 3.41 | Why? |
| Adrenomedullin | 6 | 2018 | 217 | 3.16 | Why? |
| Sepsis | 20 | 2021 | 3517 | 2.35 | Why? |
| Endotoxins | 4 | 2019 | 80 | 1.60 | Why? |
| Delirium | 12 | 2019 | 1061 | 1.21 | Why? |
| Lipopolysaccharides | 11 | 2021 | 848 | 1.15 | Why? |
| Oligopeptides | 2 | 2019 | 576 | 1.14 | Why? |
| Haloperidol | 3 | 2018 | 78 | 1.04 | Why? |
| Antibodies | 3 | 2018 | 846 | 1.02 | Why? |
| Acute Kidney Injury | 9 | 2020 | 5762 | 1.02 | Why? |
| Shock, Septic | 6 | 2020 | 1313 | 0.99 | Why? |
| Alkaline Phosphatase | 3 | 2018 | 257 | 0.93 | Why? |
| Lot Quality Assurance Sampling | 1 | 2019 | 2 | 0.80 | Why? |
| Capillary Permeability | 2 | 2018 | 277 | 0.79 | Why? |
| Precision Medicine | 3 | 2021 | 1477 | 0.78 | Why? |
| Vasodilation | 2 | 2018 | 258 | 0.76 | Why? |
| Chorionic Gonadotropin | 1 | 2018 | 30 | 0.76 | Why? |
| Intensive Care Units | 25 | 2022 | 29594 | 0.75 | Why? |
| Vasoplegia | 1 | 2018 | 27 | 0.73 | Why? |
| Critical Illness | 19 | 2022 | 17281 | 0.68 | Why? |
| Hemofiltration | 1 | 2019 | 155 | 0.67 | Why? |
| Membranes, Artificial | 1 | 2019 | 175 | 0.67 | Why? |
| Norepinephrine | 1 | 2018 | 152 | 0.67 | Why? |
| Renal Replacement Therapy | 4 | 2020 | 1530 | 0.62 | Why? |
| Case Management | 1 | 2018 | 285 | 0.61 | Why? |
| Netherlands | 12 | 2022 | 3533 | 0.61 | Why? |
| Testosterone | 1 | 2021 | 596 | 0.59 | Why? |
| Enterocytes | 1 | 2018 | 245 | 0.59 | Why? |
| Protective Agents | 1 | 2018 | 250 | 0.59 | Why? |
| Inservice Training | 1 | 2018 | 477 | 0.54 | Why? |
| Patient Outcome Assessment | 1 | 2018 | 707 | 0.53 | Why? |
| Creatinine | 3 | 2020 | 1443 | 0.52 | Why? |
| Antibodies, Monoclonal, Humanized | 3 | 2021 | 9335 | 0.51 | Why? |
| Hemoperfusion | 1 | 2017 | 260 | 0.50 | Why? |
| Common Cold | 1 | 2018 | 645 | 0.46 | Why? |
| Rhinovirus | 1 | 2018 | 979 | 0.46 | Why? |
| Standard of Care | 2 | 2017 | 1297 | 0.42 | Why? |
| Neutrophils | 8 | 2021 | 5476 | 0.41 | Why? |
| Critical Pathways | 2 | 2017 | 1587 | 0.41 | Why? |
| L-Selectin | 4 | 2021 | 42 | 0.40 | Why? |
| Dexamethasone | 1 | 2021 | 2055 | 0.40 | Why? |
| Cytokines | 14 | 2021 | 15010 | 0.40 | Why? |
| Body Mass Index | 2 | 2022 | 4306 | 0.39 | Why? |
| Coinfection | 2 | 2021 | 6820 | 0.38 | Why? |
| Fatty Acid-Binding Proteins | 3 | 2018 | 93 | 0.36 | Why? |
| Kidney Diseases | 1 | 2019 | 1434 | 0.35 | Why? |
| Disease Susceptibility | 1 | 2021 | 4002 | 0.35 | Why? |
| Immunity | 1 | 2019 | 2651 | 0.35 | Why? |
| Healthy Volunteers | 6 | 2021 | 1444 | 0.35 | Why? |
| Half-Life | 2 | 2018 | 298 | 0.34 | Why? |
| Bacterial Infections | 1 | 2021 | 2229 | 0.34 | Why? |
| Endothelium, Vascular | 1 | 2018 | 1751 | 0.33 | Why? |
| Inflammation | 7 | 2021 | 13255 | 0.32 | Why? |
| DNA, Mitochondrial | 2 | 2019 | 163 | 0.32 | Why? |
| Obesity | 3 | 2022 | 7388 | 0.31 | Why? |
| Immune Tolerance | 3 | 2020 | 608 | 0.31 | Why? |
| Infusions, Intravenous | 3 | 2019 | 1224 | 0.29 | Why? |
| Antipsychotic Agents | 3 | 2018 | 887 | 0.29 | Why? |
| Patient Care Team | 2 | 2018 | 3556 | 0.28 | Why? |
| Length of Stay | 9 | 2022 | 11042 | 0.28 | Why? |
| Models, Biological | 3 | 2018 | 4907 | 0.28 | Why? |
| Humans | 90 | 2022 | 930598 | 0.28 | Why? |
| Male | 58 | 2022 | 367725 | 0.27 | Why? |
| Receptors, IgG | 5 | 2021 | 578 | 0.26 | Why? |
| Cardiac Surgical Procedures | 1 | 2017 | 1931 | 0.26 | Why? |
| Adenosine | 2 | 2018 | 509 | 0.26 | Why? |
| Nursing Staff, Hospital | 1 | 2017 | 1554 | 0.26 | Why? |
| Interleukin-10 | 3 | 2018 | 1409 | 0.24 | Why? |
| Hospital Mortality | 6 | 2022 | 22087 | 0.24 | Why? |
| Immunologic Factors | 1 | 2018 | 4206 | 0.23 | Why? |
| Dose-Response Relationship, Drug | 4 | 2018 | 3776 | 0.23 | Why? |
| Triggering Receptor Expressed on Myeloid Cells-1 | 1 | 2021 | 40 | 0.23 | Why? |
| Prospective Studies | 19 | 2021 | 43301 | 0.23 | Why? |
| Critical Care | 8 | 2020 | 14081 | 0.22 | Why? |
| Heparin Antagonists | 1 | 2020 | 21 | 0.22 | Why? |
| Multiple Trauma | 1 | 2022 | 80 | 0.22 | Why? |
| Systemic Inflammatory Response Syndrome | 3 | 2019 | 6653 | 0.21 | Why? |
| Glucocorticoids | 1 | 2017 | 4431 | 0.21 | Why? |
| Erythroid Cells | 1 | 2020 | 82 | 0.21 | Why? |
| Female | 45 | 2022 | 380317 | 0.21 | Why? |
| Respiratory Burst | 1 | 2019 | 16 | 0.20 | Why? |
| Antibodies, Monoclonal | 2 | 2018 | 8041 | 0.20 | Why? |
| Glucuronidase | 1 | 2020 | 103 | 0.20 | Why? |
| C-Reactive Protein | 4 | 2021 | 7972 | 0.20 | Why? |
| Euthyroid Sick Syndromes | 1 | 2021 | 150 | 0.20 | Why? |
| Double-Blind Method | 4 | 2018 | 5988 | 0.19 | Why? |
| Receptors, Interleukin-1 | 1 | 2020 | 161 | 0.19 | Why? |
| Aged | 34 | 2022 | 215776 | 0.19 | Why? |
| Estradiol | 1 | 2021 | 250 | 0.19 | Why? |
| Tight Junctions | 1 | 2020 | 179 | 0.19 | Why? |
| Severity of Illness Index | 8 | 2021 | 48226 | 0.19 | Why? |
| Ischemic Preconditioning | 1 | 2019 | 43 | 0.19 | Why? |
| Nontherapeutic Human Experimentation | 1 | 2018 | 11 | 0.19 | Why? |
| Molecular Targeted Therapy | 2 | 2018 | 1579 | 0.19 | Why? |
| Cecum | 1 | 2018 | 63 | 0.19 | Why? |
| Ligation | 1 | 2018 | 84 | 0.19 | Why? |
| Punctures | 1 | 2018 | 89 | 0.19 | Why? |
| Phagosomes | 1 | 2018 | 32 | 0.19 | Why? |
| Biomarkers | 11 | 2021 | 23361 | 0.18 | Why? |
| Metabolic Clearance Rate | 1 | 2018 | 110 | 0.18 | Why? |
| Anti-Inflammatory Agents | 1 | 2018 | 6153 | 0.18 | Why? |
| Gonadal Steroid Hormones | 1 | 2021 | 328 | 0.18 | Why? |
| Megakaryocytes | 1 | 2020 | 274 | 0.18 | Why? |
| NADPH Oxidases | 1 | 2018 | 80 | 0.18 | Why? |
| von Hippel-Lindau Disease | 1 | 2017 | 9 | 0.18 | Why? |
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2017 | 13 | 0.18 | Why? |
| Interleukin-1beta | 3 | 2018 | 992 | 0.18 | Why? |
| Middle Aged | 36 | 2022 | 270681 | 0.18 | Why? |
| Nocardia | 1 | 2017 | 21 | 0.17 | Why? |
| Vasopressins | 1 | 2018 | 70 | 0.17 | Why? |
| Interleukin-8 | 3 | 2018 | 964 | 0.17 | Why? |
| Illness Behavior | 1 | 2017 | 76 | 0.17 | Why? |
| Plasma Cells | 1 | 2020 | 464 | 0.17 | Why? |
| Phosphoric Diester Hydrolases | 1 | 2017 | 52 | 0.17 | Why? |
| Kidney Tubules | 1 | 2019 | 205 | 0.17 | Why? |
| Glucagon-Like Peptide 1 | 1 | 2017 | 83 | 0.17 | Why? |
| Hydrocortisone | 2 | 2019 | 1790 | 0.17 | Why? |
| Cytoreduction Surgical Procedures | 1 | 2018 | 144 | 0.17 | Why? |
| Nocardia Infections | 1 | 2017 | 37 | 0.17 | Why? |
| Monocytes | 3 | 2019 | 2978 | 0.17 | Why? |
| Antifungal Agents | 2 | 2018 | 1828 | 0.17 | Why? |
| Vasoconstrictor Agents | 2 | 2018 | 714 | 0.16 | Why? |
| Brain Abscess | 1 | 2017 | 50 | 0.16 | Why? |
| Interferon-gamma | 2 | 2017 | 2711 | 0.16 | Why? |
| Endothelium | 1 | 2020 | 460 | 0.16 | Why? |
| Toll-Like Receptor 9 | 1 | 2017 | 72 | 0.16 | Why? |
| Electrolytes | 1 | 2017 | 103 | 0.16 | Why? |
| Pancreaticoduodenectomy | 1 | 2017 | 60 | 0.16 | Why? |
| Hyperthermia, Induced | 1 | 2018 | 106 | 0.16 | Why? |
| Intention to Treat Analysis | 1 | 2018 | 673 | 0.16 | Why? |
| Interleukin-6 | 7 | 2020 | 7522 | 0.16 | Why? |
| Kidney | 3 | 2018 | 3648 | 0.16 | Why? |
| Rats, Wistar | 1 | 2018 | 621 | 0.16 | Why? |
| Self-Assessment | 1 | 2018 | 165 | 0.16 | Why? |
| Echinocandins | 1 | 2017 | 139 | 0.16 | Why? |
| Voriconazole | 1 | 2018 | 206 | 0.16 | Why? |
| Placebos | 2 | 2018 | 629 | 0.16 | Why? |
| Alarmins | 1 | 2018 | 180 | 0.16 | Why? |
| Reward | 1 | 2017 | 146 | 0.16 | Why? |
| Polymyxin B | 1 | 2017 | 93 | 0.16 | Why? |
| Phagocytosis | 1 | 2018 | 409 | 0.16 | Why? |
| Blood Pressure | 2 | 2018 | 2198 | 0.15 | Why? |
| Physical Exertion | 1 | 2017 | 176 | 0.15 | Why? |
| Human Experimentation | 1 | 2018 | 146 | 0.15 | Why? |
| Ticlopidine | 1 | 2017 | 193 | 0.15 | Why? |
| Chest Tubes | 1 | 2017 | 177 | 0.15 | Why? |
| Confidentiality | 1 | 2021 | 581 | 0.15 | Why? |
| Adult | 30 | 2021 | 244371 | 0.15 | Why? |
| Ileum | 1 | 2017 | 233 | 0.15 | Why? |
| Cardiotonic Agents | 1 | 2018 | 418 | 0.15 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.15 | Why? |
| Histones | 1 | 2018 | 371 | 0.15 | Why? |
| Purinergic P2Y Receptor Antagonists | 1 | 2017 | 206 | 0.15 | Why? |
| Kidney Tubules, Proximal | 1 | 2016 | 178 | 0.15 | Why? |
| Intra-Abdominal Hypertension | 1 | 2015 | 36 | 0.14 | Why? |
| Lipopeptides | 1 | 2017 | 229 | 0.14 | Why? |
| Compartment Syndromes | 1 | 2015 | 36 | 0.14 | Why? |
| Organ Dysfunction Scores | 2 | 2018 | 1475 | 0.14 | Why? |
| HLA-DR Antigens | 1 | 2017 | 563 | 0.14 | Why? |
| Patient Acuity | 1 | 2022 | 1755 | 0.14 | Why? |
| Pneumonia, Bacterial | 1 | 2022 | 843 | 0.14 | Why? |
| Hypotension | 1 | 2018 | 392 | 0.14 | Why? |
| Area Under Curve | 2 | 2018 | 2564 | 0.14 | Why? |
| Invasive Fungal Infections | 1 | 2018 | 274 | 0.13 | Why? |
| Intestinal Diseases | 1 | 2017 | 231 | 0.13 | Why? |
| Datasets as Topic | 1 | 2021 | 1404 | 0.13 | Why? |
| Leukocytes | 2 | 2021 | 1046 | 0.13 | Why? |
| Adrenal Insufficiency | 1 | 2017 | 190 | 0.13 | Why? |
| B7-H1 Antigen | 1 | 2017 | 541 | 0.13 | Why? |
| Checklist | 1 | 2019 | 714 | 0.13 | Why? |
| Ventilator-Induced Lung Injury | 1 | 2017 | 260 | 0.13 | Why? |
| Emergency Service, Hospital | 1 | 2018 | 14232 | 0.13 | Why? |
| Spleen | 1 | 2017 | 877 | 0.13 | Why? |
| Mitochondria | 2 | 2019 | 857 | 0.13 | Why? |
| Candidiasis | 1 | 2017 | 334 | 0.13 | Why? |
| Immunocompromised Host | 3 | 2019 | 5150 | 0.13 | Why? |
| Platelet Activation | 1 | 2017 | 660 | 0.12 | Why? |
| Leukocyte Disorders | 1 | 2012 | 20 | 0.12 | Why? |
| Hypoxia | 2 | 2018 | 3626 | 0.12 | Why? |
| Animals | 9 | 2019 | 78931 | 0.12 | Why? |
| Cohort Studies | 8 | 2020 | 36005 | 0.12 | Why? |
| Time Factors | 5 | 2019 | 31397 | 0.12 | Why? |
| Anti-Bacterial Agents | 3 | 2020 | 10083 | 0.12 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 1165 | 0.12 | Why? |
| Myeloid Cells | 1 | 2017 | 808 | 0.12 | Why? |
| Nasal Cavity | 1 | 2018 | 909 | 0.12 | Why? |
| Lymphopenia | 2 | 2021 | 2669 | 0.12 | Why? |
| Delphi Technique | 1 | 2017 | 1257 | 0.12 | Why? |
| Antimicrobial Stewardship | 1 | 2020 | 931 | 0.12 | Why? |
| Reactive Oxygen Species | 1 | 2018 | 1136 | 0.12 | Why? |
| Programmed Cell Death 1 Receptor | 1 | 2017 | 724 | 0.12 | Why? |
| Leukocytes, Mononuclear | 2 | 2021 | 2115 | 0.11 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 711 | 0.11 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2020 | 1731 | 0.11 | Why? |
| Bronchoscopy | 1 | 2019 | 991 | 0.11 | Why? |
| Long QT Syndrome | 1 | 2021 | 1047 | 0.11 | Why? |
| Rats | 1 | 2018 | 2764 | 0.11 | Why? |
| Intestines | 1 | 2017 | 817 | 0.11 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.11 | Why? |
| Cells, Cultured | 5 | 2021 | 5835 | 0.11 | Why? |
| Tumor Necrosis Factor-alpha | 2 | 2018 | 2483 | 0.11 | Why? |
| Feasibility Studies | 2 | 2018 | 3467 | 0.10 | Why? |
| Decision Support Techniques | 1 | 2018 | 903 | 0.10 | Why? |
| Escherichia coli | 1 | 2018 | 1547 | 0.10 | Why? |
| Hematology | 1 | 2017 | 649 | 0.10 | Why? |
| Aftercare | 1 | 2020 | 1637 | 0.10 | Why? |
| Psychometrics | 1 | 2018 | 1269 | 0.10 | Why? |
| Young Adult | 14 | 2021 | 93724 | 0.10 | Why? |
| Safety Management | 1 | 2018 | 1093 | 0.10 | Why? |
| Blood Circulation | 2 | 2020 | 99 | 0.10 | Why? |
| Recombinant Proteins | 2 | 2017 | 3786 | 0.10 | Why? |
| Clinical Protocols | 2 | 2018 | 2734 | 0.10 | Why? |
| Heart Rate | 1 | 2019 | 1527 | 0.10 | Why? |
| Interdisciplinary Communication | 1 | 2017 | 1425 | 0.10 | Why? |
| Extracellular Traps | 1 | 2018 | 1036 | 0.10 | Why? |
| Liver Cirrhosis | 1 | 2021 | 1810 | 0.10 | Why? |
| Adaptive Immunity | 1 | 2021 | 2585 | 0.09 | Why? |
| Aspirin | 1 | 2017 | 1043 | 0.09 | Why? |
| Leukocyte Count | 1 | 2019 | 3178 | 0.09 | Why? |
| Propensity Score | 1 | 2017 | 2690 | 0.09 | Why? |
| Cognition | 1 | 2018 | 1394 | 0.09 | Why? |
| Respiratory Insufficiency | 3 | 2019 | 7301 | 0.09 | Why? |
| Stroke Volume | 1 | 2018 | 2153 | 0.09 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2018 | 10649 | 0.09 | Why? |
| Wounds and Injuries | 1 | 2021 | 1708 | 0.09 | Why? |
| Immune System Diseases | 1 | 2012 | 410 | 0.09 | Why? |
| Hospitals, University | 2 | 2018 | 4173 | 0.09 | Why? |
| Noninvasive Ventilation | 2 | 2019 | 2329 | 0.09 | Why? |
| Respiration, Artificial | 4 | 2020 | 22116 | 0.09 | Why? |
| Drug Delivery Systems | 1 | 2017 | 1365 | 0.09 | Why? |
| Drug Evaluation, Preclinical | 1 | 2019 | 3347 | 0.08 | Why? |
| Transcriptome | 1 | 2021 | 3466 | 0.08 | Why? |
| Sleep Wake Disorders | 1 | 2019 | 1463 | 0.08 | Why? |
| Clinical Decision-Making | 1 | 2021 | 3755 | 0.08 | Why? |
| Vitamin D Deficiency | 1 | 2020 | 1782 | 0.08 | Why? |
| Risk Assessment | 4 | 2021 | 25439 | 0.08 | Why? |
| Motivation | 1 | 2017 | 1640 | 0.08 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2017 | 1671 | 0.08 | Why? |
| Plasma | 1 | 2017 | 1809 | 0.08 | Why? |
| Mice | 4 | 2018 | 21357 | 0.08 | Why? |
| Perioperative Care | 1 | 2017 | 1329 | 0.08 | Why? |
| Cognitive Dysfunction | 1 | 2018 | 1389 | 0.08 | Why? |
| Sleep | 1 | 2019 | 2695 | 0.08 | Why? |
| Hematologic Neoplasms | 1 | 2019 | 2105 | 0.08 | Why? |
| Chloroquine | 1 | 2021 | 3152 | 0.08 | Why? |
| Survivors | 1 | 2018 | 2619 | 0.07 | Why? |
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2018 | 291 | 0.07 | Why? |
| Europe | 2 | 2019 | 12702 | 0.07 | Why? |
| Adolescent | 11 | 2019 | 86841 | 0.07 | Why? |
| Machine Learning | 1 | 2021 | 4395 | 0.07 | Why? |
| Epithelial Cells | 1 | 2016 | 3508 | 0.07 | Why? |
| Disease Models, Animal | 2 | 2019 | 10998 | 0.07 | Why? |
| Signal Transduction | 2 | 2018 | 7207 | 0.07 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.07 | Why? |
| Immunity, Innate | 2 | 2021 | 6570 | 0.07 | Why? |
| Candida | 2 | 2019 | 425 | 0.07 | Why? |
| Oxygen Inhalation Therapy | 1 | 2017 | 3629 | 0.07 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 7868 | 0.06 | Why? |
| Mice, Inbred C57BL | 3 | 2017 | 5542 | 0.06 | Why? |
| Up-Regulation | 2 | 2021 | 2249 | 0.06 | Why? |
| Sequence Analysis, RNA | 2 | 2021 | 2290 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2017 | 3550 | 0.05 | Why? |
| Medical Oncology | 1 | 2017 | 3826 | 0.05 | Why? |
| Triage | 1 | 2020 | 7151 | 0.05 | Why? |
| Chemokines | 2 | 2017 | 1095 | 0.05 | Why? |
| Models, Theoretical | 1 | 2019 | 6659 | 0.05 | Why? |
| Incidence | 3 | 2018 | 25622 | 0.05 | Why? |
| Drug Monitoring | 2 | 2018 | 1408 | 0.05 | Why? |
| Clinical Trials as Topic | 1 | 2019 | 7330 | 0.05 | Why? |
| Acute Disease | 3 | 2021 | 6029 | 0.05 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.05 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.05 | Why? |
| Fever | 1 | 2017 | 7795 | 0.05 | Why? |
| Thyrotropin | 1 | 2021 | 262 | 0.05 | Why? |
| Thyroid Hormones | 1 | 2021 | 213 | 0.05 | Why? |
| Receptors, Purinergic P1 | 1 | 2018 | 17 | 0.05 | Why? |
| Receptors, Vasopressin | 1 | 2018 | 8 | 0.05 | Why? |
| Inflammation Mediators | 3 | 2017 | 2654 | 0.05 | Why? |
| Elasticity Imaging Techniques | 1 | 2021 | 194 | 0.05 | Why? |
| Guilt | 1 | 2019 | 74 | 0.05 | Why? |
| Heparitin Sulfate | 1 | 2020 | 285 | 0.05 | Why? |
| Proglucagon | 1 | 2017 | 2 | 0.05 | Why? |
| Proprotein Convertase 1 | 1 | 2017 | 3 | 0.05 | Why? |
| Myristic Acids | 1 | 2017 | 3 | 0.05 | Why? |
| Enteroendocrine Cells | 1 | 2017 | 5 | 0.05 | Why? |
| Inpatients | 1 | 2015 | 5161 | 0.05 | Why? |
| Dextran Sulfate | 1 | 2017 | 54 | 0.05 | Why? |
| Principal Component Analysis | 1 | 2021 | 689 | 0.05 | Why? |
| Glycolysis | 1 | 2019 | 208 | 0.05 | Why? |
| Claudin-3 | 1 | 2017 | 3 | 0.04 | Why? |
| Biological Variation, Population | 1 | 2018 | 69 | 0.04 | Why? |
| Haploinsufficiency | 1 | 2017 | 28 | 0.04 | Why? |
| Deuterium | 1 | 2017 | 21 | 0.04 | Why? |
| Candida parapsilosis | 1 | 2017 | 34 | 0.04 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.04 | Why? |
| Citrulline | 1 | 2017 | 36 | 0.04 | Why? |
| Antimycin A | 1 | 2016 | 5 | 0.04 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.04 | Why? |
| Intracranial Pressure | 1 | 2018 | 90 | 0.04 | Why? |
| Tidal Volume | 1 | 2020 | 565 | 0.04 | Why? |
| Cell Movement | 1 | 2021 | 695 | 0.04 | Why? |
| Coma | 1 | 2019 | 204 | 0.04 | Why? |
| Psychomotor Agitation | 1 | 2019 | 208 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2020 | 1008 | 0.04 | Why? |
| Adenosine Diphosphate | 1 | 2016 | 63 | 0.04 | Why? |
| Heart Failure | 1 | 2018 | 6638 | 0.04 | Why? |
| Dopamine | 1 | 2017 | 123 | 0.04 | Why? |
| Blood Flow Velocity | 1 | 2018 | 193 | 0.04 | Why? |
| Neuroglia | 1 | 2017 | 130 | 0.04 | Why? |
| GPI-Linked Proteins | 1 | 2018 | 317 | 0.04 | Why? |
| Treatment Outcome | 3 | 2018 | 51732 | 0.04 | Why? |
| Viral Load | 1 | 2018 | 15850 | 0.04 | Why? |
| Cell Count | 1 | 2017 | 228 | 0.04 | Why? |
| Calcium Signaling | 1 | 2017 | 133 | 0.04 | Why? |
| Case-Control Studies | 3 | 2021 | 17671 | 0.04 | Why? |
| Staining and Labeling | 1 | 2017 | 169 | 0.04 | Why? |
| Arterial Pressure | 1 | 2018 | 208 | 0.04 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.04 | Why? |
| Leukemia | 1 | 2021 | 598 | 0.04 | Why? |
| Survival Analysis | 2 | 2021 | 7592 | 0.04 | Why? |
| Vital Signs | 1 | 2018 | 257 | 0.04 | Why? |
| Reperfusion Injury | 1 | 2017 | 178 | 0.04 | Why? |
| Abdominal Cavity | 1 | 2015 | 22 | 0.04 | Why? |
| APACHE | 1 | 2018 | 682 | 0.04 | Why? |
| Epidemiologic Methods | 1 | 2019 | 392 | 0.04 | Why? |
| Cerebrovascular Circulation | 1 | 2018 | 340 | 0.04 | Why? |
| Stress, Physiological | 1 | 2019 | 378 | 0.04 | Why? |
| Monte Carlo Method | 1 | 2017 | 577 | 0.04 | Why? |
| Lipopolysaccharide Receptors | 1 | 2017 | 357 | 0.03 | Why? |
| Greece | 1 | 2021 | 2091 | 0.03 | Why? |
| Down-Regulation | 1 | 2021 | 1416 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2019 | 15421 | 0.03 | Why? |
| Colitis | 1 | 2017 | 266 | 0.03 | Why? |
| Toll-Like Receptor 4 | 1 | 2017 | 390 | 0.03 | Why? |
| Aged, 80 and over | 6 | 2021 | 88759 | 0.03 | Why? |
| Adenosine Triphosphate | 1 | 2016 | 294 | 0.03 | Why? |
| Surveys and Questionnaires | 2 | 2019 | 43792 | 0.03 | Why? |
| Leukocyte Rolling | 1 | 2012 | 7 | 0.03 | Why? |
| Administration, Intravenous | 1 | 2017 | 1115 | 0.03 | Why? |
| Consensus | 2 | 2020 | 6345 | 0.03 | Why? |
| RNA | 1 | 2021 | 1278 | 0.03 | Why? |
| Phosphorylation | 1 | 2016 | 1060 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Portugal | 1 | 2018 | 1265 | 0.03 | Why? |
| Pressure | 1 | 2015 | 289 | 0.03 | Why? |
| Glucose | 1 | 2017 | 573 | 0.03 | Why? |
| Risk Factors | 5 | 2020 | 71621 | 0.03 | Why? |
| L-Lactate Dehydrogenase | 1 | 2020 | 1995 | 0.03 | Why? |
| Body Temperature | 1 | 2017 | 875 | 0.03 | Why? |
| Cell Adhesion | 1 | 2012 | 230 | 0.03 | Why? |
| Mice, Knockout | 1 | 2017 | 1815 | 0.03 | Why? |
| Belgium | 1 | 2018 | 2064 | 0.03 | Why? |
| Regression Analysis | 1 | 2019 | 2484 | 0.03 | Why? |
| Cell Differentiation | 1 | 2017 | 1338 | 0.03 | Why? |
| Denmark | 1 | 2018 | 2654 | 0.03 | Why? |
| Single-Cell Analysis | 1 | 2020 | 2450 | 0.03 | Why? |
| Phenotype | 1 | 2021 | 4037 | 0.02 | Why? |
| Enzyme Induction | 1 | 2009 | 89 | 0.02 | Why? |
| Proteomics | 1 | 2020 | 2481 | 0.02 | Why? |
| Thoracic Surgery | 1 | 2017 | 623 | 0.02 | Why? |
| Software | 1 | 2021 | 2501 | 0.02 | Why? |
| Glutathione Transferase | 1 | 2009 | 86 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2021 | 4758 | 0.02 | Why? |
| Intestinal Mucosa | 1 | 2017 | 1046 | 0.02 | Why? |
| Nitric Oxide Synthase Type II | 1 | 2009 | 119 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2020 | 3788 | 0.02 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.02 | Why? |
| Cluster Analysis | 1 | 2017 | 3001 | 0.02 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2017 | 2886 | 0.02 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.02 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.02 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2017 | 2309 | 0.02 | Why? |
| Cross-Sectional Studies | 3 | 2020 | 53120 | 0.02 | Why? |
| Lung Diseases | 1 | 2021 | 2361 | 0.02 | Why? |
| Adjuvants, Immunologic | 1 | 2017 | 1709 | 0.02 | Why? |
| Hospitalization | 1 | 2018 | 54280 | 0.02 | Why? |
| Proteome | 1 | 2017 | 1812 | 0.02 | Why? |
| Electrocardiography | 1 | 2021 | 3957 | 0.02 | Why? |
| Chronic Disease | 1 | 2021 | 5139 | 0.02 | Why? |
| Fatigue | 1 | 2017 | 2479 | 0.02 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.02 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.02 | Why? |
| Macrophages | 1 | 2017 | 2784 | 0.02 | Why? |
| Academic Medical Centers | 1 | 2018 | 3088 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.02 | Why? |
| Vitamin D | 1 | 2020 | 2904 | 0.02 | Why? |
| Tuberculosis | 1 | 2021 | 2895 | 0.02 | Why? |
| Patient Satisfaction | 1 | 2018 | 2517 | 0.02 | Why? |
| Canada | 1 | 2018 | 6018 | 0.02 | Why? |
| Australia | 1 | 2018 | 6306 | 0.02 | Why? |
| Logistic Models | 1 | 2019 | 9089 | 0.02 | Why? |
| Flow Cytometry | 1 | 2012 | 2393 | 0.02 | Why? |
| Prognosis | 2 | 2019 | 32490 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2018 | 9893 | 0.01 | Why? |
| Rheumatic Diseases | 1 | 2018 | 2675 | 0.01 | Why? |
| Palliative Care | 1 | 2017 | 2665 | 0.01 | Why? |
| Drug Repositioning | 1 | 2021 | 5683 | 0.01 | Why? |
| Nitric Oxide | 1 | 2009 | 769 | 0.01 | Why? |
| Algorithms | 1 | 2019 | 7346 | 0.01 | Why? |
| Intubation, Intratracheal | 1 | 2017 | 3962 | 0.01 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.01 | Why? |
| Cell Line | 1 | 2016 | 12040 | 0.01 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2017 | 5837 | 0.01 | Why? |
| Patient Admission | 1 | 2017 | 5250 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.01 | Why? |
| Brain | 1 | 2017 | 5133 | 0.01 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.01 | Why? |
| Biomedical Research | 1 | 2017 | 5270 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.01 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.01 | Why? |
| Depression | 1 | 2017 | 14116 | 0.01 | Why? |
| Comorbidity | 1 | 2017 | 34796 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.01 | Why? |
| United States | 1 | 2018 | 46150 | 0.01 | Why? |
| Child | 1 | 2018 | 70012 | 0.01 | Why? |